| CAS No. | 209860-87-7 |
|---|---|
| MDL No. | MFCD08062150 |
| MF | C25H34F2O5 |
| MW | 452.50 |
| InChI Key | WSNODXPBBALQOF-VEJSHDCNSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 97% | $181 | In Stock | |
| 100 mg | 97% | $305 | In Stock | |
| 250 mg | 97% | $456 | In Stock | |
| 1 g | 97% | $1134 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Tafluprost is a prostaglandin Fα derivative of prostaglandin F2α, in which the carboxylic acid group is converted to an isopropyl ester and the 3-hydroxy-1-octenyl side chain is replaced by 3,3-difluoro-4-phenoxybut-1-enyl. It is used to treat elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Tafluprost functions as a prostaglandin receptor agonist and is classified as a prostaglandin Fα, an organofluorine compound, and an isopropyl ester. It is functionally related to prostaglandin F2α.
| CAS No. | 209860-87-7 |
|---|---|
| Product Name | Tafluprost |
| Heavy Atom Count | 32 | Rotatable Bond Count | 12 |
| Atom Stereo Count | 4 | Bond Stereo Count | 2 |
| HBA | 5 | HBD | 2 |
| TPSA | 75.990 Ų | Charge | 0 |
| Exact Mass | 452.23743 | Complexity | 747.96 |
| pKa | 11.175 | XLogP | 4.683 |
